BackOntrak- 9.50% PRF PERPETUAL USD 25 - Ser A Overview

Ontrak- 9.50% PRF PERPETUAL USD 25 - Ser A EBIT

Track Ontrak- 9.50% PRF PERPETUAL USD 25 - Ser A's EBIT ($-19M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$5.85M
46.87% YoY

As of Mar 31, 2025

Annual EBIT (TTM)

-$19.37M
8.46% YoY

Trailing 12 months ending Mar 31, 2025

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Ontrak- 9.50% PRF PERPETUAL USD 25 - Ser A (OTRKP) FAQ

The latest EBIT for OTRKP is $-19M as of March 2025. That compares with $-18M in the prior-year period — down 8.5% year over year. That is below the Healthcare sector average of $23B. Investors often review this figure alongside Ontrak- 9.50% PRF PERPETUAL USD 25 - Ser A's historical trend and sector peers before judging valuation or financial health.

Over the past year, OTRKP's EBIT moved from $-18M to $-19M — a 8.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Ontrak- 9.50% PRF PERPETUAL USD 25 - Ser A's operating scale or balance-sheet position.

Against Healthcare companies, OTRKP currently prints $-19M for EBIT, while the sector average sits near $23B. That is roughly 100.1% below the sector mean. Large gaps often invite a closer look at Ontrak- 9.50% PRF PERPETUAL USD 25 - Ser A's growth, margins, and balance sheet.

A EBIT figure of $-19M for OTRKP is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $23B. Explore the charts below for those layers of context.

After noting OTRKP's EBIT ($-19M), review year-over-year change from $-18M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.